Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study. (Q33489476)
Jump to navigation
Jump to search
scientific article published in January 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study. |
scientific article published in January 1995 |
Statements
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study (English)
M T Scimò
R Stasi
A Mastino
C Favalli
E Garaci
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference